GSK2857916 with Pomalidomide and Dexamethasone clinical trials

Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex

This study is testing a new drug, GSK2857916, alongside two existing medications (pomalidomide and dexamethasone) for people with multiple myeloma that has come back or isn't responding to treatment. Researchers want to find the safest and most effective dose.